Major depressive disorder attributed to intimate partner violence against women in North Africa and the Middle East: Global Burden of Disease Study
摘要
Intimate partner violence (IPV) in the Middle East and North Africa represents a significant issue with both clinical and societal implications. This study aimed to highlight the prevalence of major depressive disorder (MDD) linked to IPV against women in these regions, using data from the Global Burden of Disease 2021.
MethodsThe prevalence, incidence, Disability-Adjusted Life Years (DALYs), and Years of Life Lost (YLLs) associated with MDD were analyzed across all ages for the period from 1990 to 2021. DALYs due to MDD specifically attributed to intimate partner violence (IPV) against women were assessed and further broken down by country and age group. Results were presented in absolute counts as well as estimates per 100,000 population, accompanied by a 95% uncertainty interval.
ResultsThe age-standardized prevalence rate of MDD in 2021 was 4,883 per 100,000 population [95% UI: 4,013 to 5,940], marking a 16% change compared to 1990 levels. Over 14 million women in North Africa and the Middle East were affected by MDD and almost 22 million [21,810,159; 95% UI 17,783,296 to 26,732,692] incidence in 2021, this rate of incidence has nearly doubled compared to 1990. Age-standardized DALYs of MDD attributed to IPV in women in 2021 was 102.87 [95% UI 0.42 to 226.38] per 100,000. All ages count estimates of DALYs of MDD attributed to IPV against women was 314,734 [95% UI 1,307 to 692,580] in 2021. The highest age-standardized DALYs of MDD attributed to IPV was in Palestine, 180.74 [95% UI 1.11 to 416.15], followed by Afghanistan [152.62; 95% UI 0.88 to 347.86], and Tunisia [136.03; 95% UI 0.38 to 317.19] per 100,000.
DiscussionThe findings highlighted a high prevalence of depression in this super region, underscoring the significant burden posed by this mental health condition. Additionally, IPV emerged as a contributing factor to MDD. These insights emphasize the need for health policies that tackle the impact of depressive disorders while addressing the influence of IPV. Therefore it is necessary to move towards preventing the negative consequences of IPV by increasing social awareness.